A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2027, filed Sep 3, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PL SEC filings page.
Planet Labs PBC (PL) reported $378.3M in revenue over the twelve months to Jul 31, 2026, up 44.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Planet Labs is improving operating efficiency, but FY2026's cash-funded growth came with a sharply more liability-heavy balance sheet.
The business converted a net loss of$247M into operating cash flow of$134M and free cash flow of$58M , so FY2026 earnings and cash tell very different stories. Because capital expenditures consumed57.1% of operating cash flow while accounts receivable rose49.6% , the cash result appears tied partly to balance-sheet movements rather than accounting profitability alone.
Operating efficiency improved as revenue grew
The balance-sheet posture changed materially: liabilities reached
Financial Health Signals
Scored against emerging companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Planet Labs PBC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Planet Labs PBC held $640.1M in cash, cash equivalents and investments at the end of fiscal year 2026, and its operations generated $134.4M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Planet Labs PBC scores 87/100 among other emerging companies.
Not available for Planet Labs PBC, so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.
Planet Labs PBC spent $106.7M on research and development in fiscal year 2026, which was 26.5% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Planet Labs PBC scores 59/100 among other emerging companies.
Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. Planet Labs PBC scores 61/100 on it among other emerging companies.
Burn Trend ranks emerging companies on how far their operating cash flow moved between the newest fiscal year and the one two years earlier, measured against the cash the earlier year used, and a move toward generating cash ranks higher. Planet Labs PBC scores 99/100 on it among other emerging companies.
Planet Labs PBC's cash, cash equivalents and investments came to $640.1M at the end of fiscal year 2026, against $957.3M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Planet Labs PBC scores 51/100 among other emerging companies.
Planet Labs PBC scores 1.20, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $1.4B against total assets of $1.1B. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Planet Labs PBC passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
Planet Labs PBC reported a net loss of $246.9M while generating $134.4M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Planet Labs PBC reported an operating loss of $95.1M against $3.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Planet Labs PBC generated $116.1M in revenue in Q2 2027. This represents an increase of 58.1% from the same quarter a year earlier. Against the prior quarter it is up 23.3%.
Planet Labs PBC's EBITDA was -$2.7M in Q2 2027, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Planet Labs PBC reported a net loss of $9.4M in Q2 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Planet Labs PBC earned -$0.03 per diluted share (EPS) in Q2 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Planet Labs PBC generated $25.6M in free cash flow in Q2 2027, representing cash available after capex. This represents a decrease of 46.1% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Planet Labs PBC held $415.1M in cash as of Q2 2027; no long-term debt figure is on record for that period.
Not reported for Q2 2027.
Margins & Returns
Planet Labs PBC's gross margin was 56.5% in Q2 2027, indicating the percentage of revenue retained after direct costs. This is down 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.0 percentage points.
Planet Labs PBC's operating margin was -11.6% in Q2 2027, reflecting core business profitability. This is up 12.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 25.4 percentage points.
Planet Labs PBC's net profit margin was -8.1% in Q2 2027, showing the share of revenue converted to profit. This is up 22.7 percentage points from the same quarter a year earlier.
Planet Labs PBC's quarterly ROE was -1.7% in Q2 2027: one quarter's net income over shareholder equity, not annualized. This is up 3.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 29.6 percentage points.
Capital Allocation
Planet Labs PBC invested $35.2M in research and development in Q2 2027. This represents an increase of 45.5% from the same quarter a year earlier. Against the prior quarter it is up 5.2%.
Planet Labs PBC invested $27.3M in capex in Q2 2027, funding long-term assets and infrastructure. This represents an increase of 34.8% from the same quarter a year earlier. Against the prior quarter it is up 58.0%.
Not reported for Q2 2027.
PL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $116.1M+58.1% | $94.2M+42.1% | $86.8M+41.1% | $81.3M+32.6% | $73.4M+20.1% | $66.3M+9.6% | $61.6M+4.6% | $61.3M+10.6% |
| Cost of Revenue | $50.4M+62.0% | $43.7M+47.5% | $39.8M+70.5% | $34.7M+46.0% | $31.1M+8.1% | $29.7M+3.1% | $23.3M-11.5% | $23.7M-19.1% |
| Gross Profit | $65.6M+55.3% | $50.4M+37.7% | $47.0M+23.1% | $46.6M+24.2% | $42.3M+30.8% | $36.6M+15.5% | $38.2M+17.7% | $37.5M+44.1% |
| R&D Expenses | $35.2M+45.5% | $33.4M+44.8% | $32.2M+40.3% | $27.3M+8.4% | $24.2M-11.4% | $23.1M-9.8% | $23.0M-19.2% | $25.2M-23.6% |
| SG&A Expenses | $44.0M+21.9% | $51.9M+42.9% | $50.8M+46.8% | $37.6M+7.7% | $36.1M-19.2% | $36.3M-10.7% | $34.6M-8.8% | $34.9M-14.6% |
| Operating Income | -$13.5Mn/m | -$34.9Mn/m | -$36.0Mn/m | -$18.3Mn/m | -$18.0Mn/m | -$22.8Mn/m | -$19.4Mn/m | -$22.6Mn/m |
| EBITDA | -$2.7Mn/m | -$23.7Mn/m | -$25.8Mn/m | -$8.4Mn/m | -$7.3Mn/m | -$11.7Mn/m | -$10.1Mn/m | -$12.5Mn/m |
| Interest Expense | $1.4M+353.9% | $1.4M+189.8% | $1.6M | $1.0M+268.2% | $317K | $499K | N/A | $277K |
| Income Tax | $733K+47.5% | $1.0M+8.9% | $2.4M+123.2% | $784K+3036.0% | $497K-44.6% | $928K+110.0% | $1.1Mn/m | $25K-93.0% |
| Net Income | -$9.4Mn/m | -$138.9Mn/m | -$152.5Mn/m | -$59.2Mn/m | -$22.6Mn/m | -$12.6Mn/m | -$35.2Mn/m | -$20.1Mn/m |
| EPS (Basic) | -$0.03n/m | -$0.40n/m | -$0.49n/m | -$0.19n/m | -$0.07n/m | -$0.04n/m | -$0.12n/m | -$0.07n/m |
| EPS (Diluted) | -$0.03n/m | -$0.40n/m | -$0.49n/m | -$0.19n/m | -$0.07n/m | -$0.04n/m | -$0.12n/m | -$0.07n/m |
| Diluted Shares (Avg) | 360M+18.2% | 346M+15.1% | N/A | 309M+5.4% | 304M+4.7% | 300M+4.2% | N/A | 293M+3.2% |
PL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.4B+105.5% | $1.3B+90.1% | $1.1B+80.8% | $1.1B+75.4% | $696.4M+5.8% | $658.4M-2.4% | $633.8M-9.7% | $630.8M-11.6% |
| Current Assets | $998.8M+181.0% | $849.0M+161.4% | $775.4M+156.6% | $754.1M+150.1% | $355.5M+8.8% | $324.8M-6.1% | $302.2M-18.4% | $301.6M-22.2% |
| Cash & Equivalents | $415.1M+129.2% | $368.1M+175.8% | $229.4M+94.4% | $443.3M+219.0% | $181.1M+22.1% | $133.5M+24.3% | $118.0M+40.8% | $139.0M+36.9% |
| Short-Term Investments | $450.3M+397.8% | $362.7M+291.6% | $410.6M+294.8% | $234.0M+126.6% | $90.5M-10.5% | $92.6M-44.9% | $104.0M-51.6% | $103.3M-51.6% |
| Inventory | $8.9M | $9.3M | $6.1Mn/m | N/A | N/A | N/A | $0 | N/A |
| Accounts Receivable | $59.9M+16.0% | $61.6M-17.5% | $83.5M+49.6% | $46.3M+19.2% | $51.6M+17.5% | $74.7M+93.8% | $55.8M+28.9% | $38.9M-13.9% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $142.7M+2.9% | $143.1M+3.3% | $143.5M+5.2% | $139.0M+1.1% | $138.6M+1.0% | $138.5M+1.0% | $136.3M+0.1% | $137.4M+1.3% |
| Total Liabilities | $866.6M+232.4% | $807.7M+278.2% | $957.3M+397.2% | $756.5M+355.3% | $260.7M+40.9% | $213.6M+22.6% | $192.5M+4.6% | $166.2M-7.6% |
| Current Liabilities | $351.3M+72.6% | $302.5M+95.8% | $469.5M+230.4% | $188.6M+46.1% | $203.5M+45.7% | $154.6M+22.3% | $142.1M+4.0% | $129.1M-1.6% |
| Non-Current Liabilities | $515.3M+800.2% | $505.2M+755.7% | $487.8M+867.2% | $567.9M+1431.8% | $57.2M+26.0% | $59.0M+23.2% | $50.4M+6.6% | $37.1M-24.0% |
| Total Equity | $564.4M+29.5% | $443.7M-0.2% | $188.4M-57.3% | $349.6M-24.8% | $435.7M-7.9% | $444.8M-11.1% | $441.3M-14.8% | $464.6M-12.9% |
| Retained Earnings | -$1.6Bn/m | -$1.6Bn/m | -$1.4Bn/m | -$1.3Bn/m | -$1.2Bn/m | -$1.2Bn/m | -$1.2Bn/m | -$1.2Bn/m |
Not reported in any period shown, so not listed: Long-Term Debt.
PL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $52.9M-21.9% | $15.4M-11.0% | $20.6Mn/m | $28.6M+601.5% | $67.8Mn/m | $17.3Mn/m | -$6.3Mn/m | $4.1Mn/m |
| Depreciation & Amortization | $10.8M+1.6% | $11.2M+1.0% | $10.2M+10.1% | $9.9M-2.1% | $10.6M-19.2% | $11.1M-15.4% | $9.3M-20.1% | $10.1M-25.7% |
| Stock-Based Compensation | $17.1M+26.8% | $16.5M+31.2% | N/A | $13.5M+13.9% | $13.5M+16.3% | $12.5M-4.1% | N/A | $11.8M-6.1% |
| Capital Expenditures | $27.3M+34.8% | $17.3M+113.2% | $21.6M+86.2% | $26.7M+249.8% | $20.3M+34.2% | $8.1M-18.3% | $11.6M+30.3% | $7.6M+3.5% |
| Free Cash Flow | $25.6M-46.1% | -$1.9M-120.3% | -$951Kn/m | $1.9Mn/m | $47.5Mn/m | $9.2Mn/m | -$17.9Mn/m | -$3.6Mn/m |
| Investing Cash Flow | -$117.4Mn/m | $30.4M+1647.9% | -$204.4Mn/m | -$171.0Mn/m | -$19.4M-137.9% | $1.7M-94.3% | -$13.1Mn/m | -$10.7M-152.7% |
| Financing Cash Flow | $113.8Mn/m | $95.2Mn/m | -$31.0Mn/m | $398.3Mn/m | -$1.0Mn/m | -$9.2Mn/m | -$233Kn/m | -$10.2Mn/m |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
PL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 56.5%-1.0pp | 53.5%-1.7pp | 54.2%-7.9pp | 57.3%-3.9pp | 57.6%+4.7pp | 55.2%+2.8pp | 62.1%+6.9pp | 61.2%+14.2pp |
| Operating Margin | -11.6%+12.8pp | -37.1%-2.7pp | -41.5%-10.0pp | -22.6%+14.3pp | -24.5%+40.3pp | -34.4%+22.8pp | -31.5%+26.2pp | -36.9%+49.5pp |
| Net Margin | -8.1%+22.7pp | -147.5% | -175.6% | -72.8%-40.1pp | -30.8%+32.5pp | -19.1%+29.4pp | -57.1%-6.0pp | -32.8%+35.8pp |
| Return on Equity | -1.7%+3.5pp | -31.3%-28.5pp | -80.9%-72.9pp | -16.9%-12.6pp | -5.2%+3.0pp | -2.8%+3.0pp | -8.0%-2.2pp | -4.3%+2.8pp |
| Return on Assets | -0.7%+2.6pp | -11.1%-9.2pp | -13.3%-7.8pp | -5.3%-2.2pp | -3.2%+2.6pp | -1.9%+2.4pp | -5.5%-1.3pp | -3.2%+2.1pp |
| Current Ratio | 2.84+1.1x | 2.81+0.7x | 1.65-0.5x | 4.00+1.7x | 1.75-0.6x | 2.10-0.6x | 2.13-0.6x | 2.34-0.6x |
| Liabilities-to-Equity | 1.54+0.9x | 1.82+1.3x | 5.08+4.6x | 2.16+1.8x | 0.60+0.2x | 0.48+0.1x | 0.44+0.1x | 0.360.0x |
| Asset Turnover | 0.080.0x | 0.080.0x | 0.080.0x | 0.070.0x | 0.110.0x | 0.100.0x | 0.100.0x | 0.100.0x |
| FCF Margin | 22.1%-42.6pp | -2.0%-15.9pp | -1.1%+28.0pp | 2.3%+8.1pp | 64.7%+102.3pp | 13.9%+37.5pp | -29.1%-2.3pp | -5.8%+48.8pp |
Not reported in any period shown, so not listed: Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Planet Labs PBC PL | FY2026 | $307.7M | -$246.9M | -80.2% | $4.2B | 71/100 |
| Mercury Systems Inc. MRCY | FY2026 | $983.6M | -$29.7M | -3.0% | $4.7B | 50/100 |
| Firefly Aerospace FLY | FY2025 | $159.9M | -$298.3M | N/A | $3.4B | 53/100 |
| AeroVironment, Inc. AVAV | FY2026 | $2.0B | -$265.1M | -13.4% | $4.9B | 54/100 |
| Karman Holdings Inc. KRMN | FY2025 | $471.5M | $17.4M | 3.7% | $4.4B | 59/100 |
| VSE Corp VSEC | FY2025 | $1.1B | $11.7M | 1.1% | $5.2B | 58/100 |
Where Planet Labs PBC Ranks
Frequently Asked Questions
Planet Labs PBC (PL) reported $307.7M in total revenue for fiscal year 2026. This represents a 25.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Planet Labs PBC (PL) revenue grew by 25.9% year-over-year, from $244.4M to $307.7M in fiscal year 2026.
No, Planet Labs PBC (PL) reported a net loss of $359.9M over the trailing 12 months to July 31, 2026. In fiscal year 2026 it reported a net loss of $246.9M, with a net profit margin of -80.2%.
Planet Labs PBC (PL) had EBITDA of -$53.2M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
Planet Labs PBC (PL) had a gross margin of 56.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
Planet Labs PBC (PL) had an operating margin of -30.9% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
Planet Labs PBC (PL) had a net profit margin of -80.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
Planet Labs PBC (PL) has a return on equity of -131.0% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
Planet Labs PBC (PL) generated $57.6M in free cash flow during fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Planet Labs PBC (PL) generated $134.4M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
Planet Labs PBC (PL) had $1.1B in total assets as of fiscal year 2026, including both current and long-term assets.
Planet Labs PBC (PL) invested $76.7M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
Planet Labs PBC (PL) invested $106.7M in research and development during fiscal year 2026.
Planet Labs PBC (PL) had a current ratio of 1.65 as of fiscal year 2026, which is generally considered healthy.
Planet Labs PBC (PL) had a liabilities-to-equity ratio of 5.08 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2026, because the filing data we hold for that year carries no long-term debt figure.
Planet Labs PBC (PL) had a return on assets of -21.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
Planet Labs PBC (PL) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to July 31, 2026). The market capitalization is $4.2B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Planet Labs PBC (PL) trades at 11.2x sales, its market capitalization divided by $378.3M revenue, trailing 12 months to July 31, 2026. The market capitalization is $4.2B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Planet Labs PBC (PL) has an Altman Z-Score of 1.20, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Planet Labs PBC (PL) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Planet Labs PBC (PL) reported a net loss of $246.9M while generating $134.4M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Planet Labs PBC (PL) reported an operating loss of $95.1M against $3.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
Planet Labs PBC (PL) scores 71 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Planet Labs PBC it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.